抗癌药物致急性肾损伤
本文综述抗癌药物所致急性肾损伤(AKI),强调该损伤可累及所有肾单位节段,机制包括直接细胞毒性与免疫介导效应。识别高危患者并纠正危险因素、评估基线肾功能、调整剂量及避免肾毒性药物联用有助于预防或减轻肾毒性,及时识别并停用或减量可疑药物对肾功能恢复至关重要。
要点
- 抗癌药物致AKI可累及血管、肾小球、肾小管和间质。
- 用药前评估基线肾功能并纠正危险因素可预防或减轻肾毒性。
- 及时识别并停用或减量可疑药物对肾功能恢复至关重要。
核心结论
- 抗癌药物毒性是AKI的重要且日益增多的原因,可影响所有肾单位节段。
主要发现
- 近期研究加深了对药物致AKI亚细胞机制的认识,包括直接细胞毒性和免疫介导效应。
临床怎么用
- 用药前识别高危患者、评估基线肾功能、调整药物剂量并避免肾毒性药物联用。
- 及时识别药物致AKI并停用或减量可疑药物,以最大化肾功能恢复。
- 纠正患者相关和药物相关危险因素以预防或减轻肾毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute kidney injury (AKI) is a growing problem with untoward economic and medical consequences. Anticancer drug toxicity remains an important and increasing cause of AKI. Importantly, drug-induced AKI affects all nephron segments-vasculature, glomerulus, tubules, and interstitium. Recent studies have increased insight into the subcellular mechanisms of drug-induced AKI that include direct cellular toxicity and immune-mediated effects. Identification of patients with high-risk cancer before drug exposure may allow prevention or at least a reduction in the development and severity of nephrotoxicity. Recognition of drug-induced AKI and rapid discontinuation (or dose reduction) of the offending agents, when appropriate, are critical to maximizing kidney function recovery. Preventive measures require understanding patient and drug-related risk factors coupled with correcting risk factors, assessing baseline kidney function before initiation of therapy, adjusting the drug dosage and avoiding use of nephrotoxic drug combinations.
引用
- Izzedine H, Perazella MA. Anticancer Drug-Induced Acute Kidney Injury. Kidney Int Rep. 2017. PMID: 29318217. doi:10.1016/j.ekir.2017.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。